UnitedHealth’s dividend payout, currently $1.45 per share, and the performance of its shares, which are up almost 30% this year, make the company an attractive buy right now.
But the insurance and healthcare leader is well positioned to weather any long-term financial tumult as well.
Regardless of what happens to the economy, Americans are still going to need healthcare, and millions of them are already UnitedHealth customers.
UnitedHealth is a diversified company. In addition to its thriving insurance business, it also provides software and information technology to a number of clinics and hospitals.
As the medical tech space continues to grow, so should UnitedHealth’s profits.
U.S. Bancorp (USB)
U.S. Bancorp is the parent company of U.S. Bank, one of the country’s largest banking institutions.
Betting on bank stock might seem counterintuitive when a stock market correction is expected to hammer investors’ finances. But banks tend to do well in rising interest rate environments: As rates increase, the profit margin, or spread, earned by banks widens.
Rather than turning itself into a casino through the kinds of risky derivative plays that tanked some of its competitors in 2007-2008, U.S. Bancorp has instead been focused on innovating and providing digital service for its customers.
The increased efficiency and lower operating costs that result should be music to investors’ ears.
Since the beginning of 2021, U.S. Bancorp stock has risen by almost 32%. Of course, if you’re on the fence about jumping in at the current level, some apps might give you a free share of U.S. Bancorp just for signing up.
Despite the push for more healthy food and beverage consumption, Coca-Cola’s dominance of the soft drink market remains unmatched.
But the company’s offerings extend far beyond liquid sugar.
Coke also sells popular bottled water brands Dasani and Smartwater, big-name juices like Minute Maid and Simply, and international coffee products Costa and Georgia.
What makes Coca-Cola an interesting defensive play is the company’s consistently impressive profit margin, which has averaged 23.6% over the last decade. That’s largely the result of Coke’s ability to tinker with portion sizes and prices and having the capital to invest in greater productivity.
A faltering stock market shouldn’t change any of those dynamics.
This year, Coke’s quarterly dividend payout hit $0.42, almost double what it was in 2011.
Get a piece of commercial real estate
Don’t forget about inflation
A market correction isn’t the only thing portfolios need protection from.
Inflation, which hit a 13-year high in September, can also make short work of your returns.
At times of high inflation, investors often turn to real assets, which tend to hold their value. Real estate and commodities are traditional choices, but collectibles — diamonds, wine, fine art — are taking up an increasing amount of room in modern portfolios.
Investing in fine art no longer requires you to outbid a gaggle of millionaires at some stuffy auction house.
A new platform allows you to purchase shares of modern masterpieces by artists like Andy Warhol, Banksy, and even Claude Monet — without breaking the bank.
Pour your portfolio a glass of recession resistance
Fine wine is a sweet comfort in any situation — and now it can make your investment portfolio a little more comfortable, too.
Ownership in real assets like fine wine could be the diversification you need to protect your portfolio against the volatile effects of inflation and recession. High-net-worth investors have kept this secret to themselves for too long.
Now a platform called Vinovest helps everyday buyers invest in fine wines — no sommelier certification required.
Vinovest automatically selects the best wines for your portfolio based on your goals, and it tells you the best times to sell to get the best value for your wine.